Skip to main content
. 2016 May 23;2016(5):CD007126. doi: 10.1002/14651858.CD007126.pub3

Abdulla 2012a.

Methods Double‐blind, placebo and active‐controlled, multiple dose, over 24 h
First dose administered 15 min prior to extubation
Participants Type of surgery: thyroidectomy
Paracetamol group
Entered/completing: 30/30
Age (mean, SD): 44.5 ± 15.1
Sex (male, %): 16.7%
Placebo
Entered/completing: 30/30
Age (mean, SD): 47.9 ± 11.8
Sex (male, %): 10.0%
Parecoxib
Entered/completing: 30/30
Age (mean, SD): 48.3 ± 14.2
Sex (male, %): 23.3%
Metamizole
Entered/completing: 30/30
Age (mean, SD): 43.8 ± 13.7
Sex (male, %): 16.7%
Interventions 1 g paracetamol in 100 ml normal saline over 15 min
Placebo, parecoxib 40 mg, or metamizole 1 g: all in 100 ml NS over 15 min
Outcomes Primary: accumulated opioid consumption (piritramide via PCA)
Secondary:
Pain intensity (VAS)
Pain relief (VRS)
Patient satisfaction (VRS)
Source of funding Not mentioned
Were treatment groups comparable at baseline? Yes
Details of preoperative pain Participants with chronic pain were excluded
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomization (http://www.randomization.com)
Allocation concealment (selection bias) Low risk Sealed, opaque envelope, only opened in emergency
Blinding (performance bias and detection bias) 
 All outcomes Low risk “The study solutions were clear so that they could not be recognized by the anesthesiologists collecting the data and were prepared by one of the researchers who was not involved in the intraoperative and postoperative treatment of these patients”.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No dropouts or protocol violations – complete data set obtained for all 4 groups
Selective reporting (reporting bias) Unclear risk All outcomes from Methods section reported in Results section, but side effects not monitored adequately
Size High risk Fewer than 50 participants per arm of the study (30 paracetamol, 30 placebo, 30 parecoxib, 30 metamizole)